Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Herpes zoster, Neck mass, Rash, Vaccination site rash
Clinical narrative: Rash appared on the back of my neck; Became quite uncomfortable; Shingles; Rash at the injection site; Lumps on back of neck; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles), NECK MASS (Lumps on back of neck), DISCOMFORT (Became quite uncomfortable), RASH (Rash appared on the back of my neck) and VACCINATION SITE RASH (Rash at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression since 1974, Hypercholesterolaemia (High cholesterol) since 2006, Acid reflux (oesophageal) since 2006, Asthma since 2010, Allergy NOS (Allergies) since 1999, Drug allergy (Paxil), Drug allergy (Luvox), Drug allergy (Effexor), Drug allergy (Sulfa), Drug allergy (Crestor), Drug allergy (Plaquenil) and Drug allergy (Myfortic). Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for Acid reflux (oesophageal), FLUTICASONE PROPIONATE (FLOVENT) for Asthma, ESCITALOPRAM OXALATE (LEXAPRO) and TRAZODONE HYDROCHLORIDE (DESYREL) for Depression, PRAVASTATIN SODIUM (PRAVACHOL) for Hypercholesterolaemia.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NECK MASS (Lumps on back of neck). On 13-Apr-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site). On 15-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). On 20-Apr-2021, the patient experienced DISCOMFORT (Became quite uncomfortable). On an unknown date, the patient experienced RASH (Rash appared on the back of my neck). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for Shingles, at a dose of 1 gram and GABAPENTIN for Shingles, at a dose of 300 mg. On 14-Apr-2021, VACCINATION SITE RASH (Rash at the injection site) had resolved. On 25-Apr-2021, DISCOMFORT (Became quite uncomfortable) had resolved. On 10-May-2021, HERPES ZOSTER (Shingles) and RASH (Rash appared on the back of my neck) had resolved. At the time of the report, NECK MASS (Lumps on back of neck) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up information received on 28-MAY-2021 contains non-significant information: Contact information updated. On 02-Jun-2021: Follow-up information received on 02-JUN-2021 contains significant information: Added patient demographics, relevant medical history (Allergies: Paxil, Luvox, Effexor, Sulfa, Crestor, Plaquenil, Myfortic; Current condition: Depression, High Cholesterol, Acid Reflux, Asthma), site of vaccine administered, concomitant medications (Lexapro, Desyrel, Pravachol, Protonix, Flovent Diskus), treatment medications. On 13-APR-2021, new event "Rash at injection site" was added which resolved on 14-APR-2021. On 15-APR-2021, new event "Shingles" was added which resolved on 10-MAY-2021. The event "Rash on my neck" resolved on 10-MAY-2021. New event "Became quite uncomfortable" was added.